CIK 0001528287 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
NeuroPace Inc
Sign in to watch- Ticker
- NPCE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 223550230
- Phone
- 6502372700
- Business address
- 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
- 4 Grant or award General Counsel and Secretary acquired 56,987 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 46,740 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 46,760 shares (grant or award)
- 4 Open-market sale General Counsel and Secretary sold 1,470 shares at $7.54 ($11,082)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Grant or award Chief Executive Officer acquired 27,000 shares (grant or award)
- 4/A Grant or award Chief Medical officer acquired 8,310 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 8,310 shares (grant or award)
- 4/A Grant or award General Counsel and Secretary acquired 5,770 shares (grant or award)
- 4 Grant or award Chief Medical officer acquired 8,181 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 26,590 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 8,181 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 5,681 shares (grant or award)
- 4 Conversion Director acquired 472,366 shares (conversion)
- 4 Conversion 10% owner acquired 3,777,281 shares (conversion)
Page 8 of 10 · 185 filings